跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LATANOPROST OPHTHALMIC SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LATANOPROST OPHTHALMIC SOLUTION
Authorized
STANDARD
LATANOPROST OPHTHALMIC SOLUTION
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f08f3a791392a4b7
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
f08f3a791392a4b7
Drug Approval Canada Name
LATANOPROST OPHTHALMIC SOLUTION
Product Name
LATANOPROST OPHTHALMIC SOLUTION
Status
Cancelled Post Market
Status Date
2025-05-01
Original Market Date
2020-06-26
Din
02489570
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.28
Atc Original
S01EE01 LATANOPROST
Atc Name
s 01 ee 01
Aig Number
0132916001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
LATANOPROST
50 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f08f3a791392a4b7
Type
Standard
Back to Health Canada Approvals